Ready to discover if semaglutide is right for you
Novos Wegovy and Lillys Zepbound are mentioned in the organizations new guidelines as drugs that should be considered when the goal is to prevent cardiovascular disease
The Biology Problem: Why Many GLP-1 Users Quit or Dont Respond While GLP-1 medications such as Wegovy, Ozempic, and Zepbound have reshaped metabolic health, real-world outcomes remain inconsistent: 3040% of users experience significant GI-related adverse effects Many experience hair loss, muscle loss, constipation, and nutrient deficiencies Nearly 25% lose less than 5% of their body weight, driven by insulin resistance, impaired glucose control, or microbiome-mediated variability in drug response
Body composition changes may be more significant than scale weight suggests
It helps suppress an appetite, which is why when Semaglutide is used with a diet and exercise program, it can lead to significant weight loss results